Craft

Guangzhou Baiyunshan Pharmaceutical

Stock Price

¥28.2

2024-10-29

Market Capitalization

¥43.3 B

2024-10-29

Revenue

¥77.1 B

FY, 2025

Guangzhou Baiyunshan Pharmaceutical Summary

Company Summary

Overview
Guangzhou Baiyunshan Pharmaceutical Holdings (广州白云山医药集团股份有限公司) is a company operating in the healthcare industry. It is engaged in the research, development, manufacturing, and sales of traditional patent medicines, western medicines, chemical raw materials, natural and biological medicines, and chemical raw materials intermediates. The company is also focused on wholesale, import, and export of medicines and medical equipment and the health industry investment in medical care, health management, health maintenance, elderly care, etc.
Type
Public
Status
Active
Founded
1997
HQ
Guangzhou, CN | view all locations
Website
http://www.gybys.com.cn/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Guangzhou, Guang Dong Sheng HQ

    China

    45 ShaMian North Street, Liwan District

Guangzhou Baiyunshan Pharmaceutical Financials

Summary Financials

Revenue (FY, 2025)
¥77.1B
Gross profit (FY, 2025)
¥12.3B
Net income (FY, 2025)
¥3.1B
Cash (FY, 2025)
¥12.6B
EBIT (FY, 2025)
¥3.5B
Enterprise value
$51.2B

Footer menu